151751-Najiba-Chargi

121 Surgery: skeletal muscle mass, systemic inflammation and flap reconstruction Table 2. Postoperative complications All patients N=616 Patients with known SMM N=413 Type of flap complication N % N % None 541 87.8 365 88.4 Flap failure 29 4.7 17 4.1 Venous congestion 14 2.3 11 2.7 Dehiscence 13 2.1 8 1.9 Partial flap failure 5 0.8 3 0.7 Thrombosis 4 0.6 2 0.5 Necrosis 4 0.6 2 0.5 Arterial congestion 3 0.5 3 0.7 Partial skin breakdown 3 0.5 2 0.5 Type of non-flap complication N % N % None 374 60.7 251 60.8 Wound infection recipient site 42 6.8 28 6.8 Wound infection donor site 40 6.5 27 6.5 Nerve damage 21 3.4 15 3.6 Wound breakdown 20 3.2 14 3.4 Postoperative bleeding 18 2.9 13 3.1 Dehiscence 14 2.3 7 1.7 Fistula 13 2.1 11 2.7 Pneumonia 13 2.1 4 1.0 Seroma 10 1.6 7 1.7 Hematoma recipient site 7 1.1 5 1.2 Neurological 6 1.0 3 0.7 Plate exposure 6 1.0 6 1.5 Pyrexia e.c.i. treated with antibiotics 5 0.8 2 0.5 Cardiovascular 4 0.6 4 1.0 Chyle leakage 3 0.5 3 0.7 Urinary tract infection 3 0.5 1 0.2 Sialocele 3 0.5 3 0.7 Swelling n.o.s. 2 0.3 3 0.7 Gastrointestinal infection 2 0.3 2 0.5 Pulmonary embolus 1 0.2 1 0.2 Other* 6 1.0 0 0 Clavien-Dindo grade N % N % 0 320 51.9 219 53 I 14 2.3 11 2.7 7